When cancer cells lost TGF-β/Smad3 tumor-suppressive responses, they could use TGF-β/Smad3 signaling to initiate immune evasion, growth factor productions, differentiation into an invasive phenotype and metastatic dissemination. This evidence concerns the gene SMAD3 and neoplasm.